192 related articles for article (PubMed ID: 21968950)
1. Debio 0507 primarily forms diaminocyclohexane-Pt-d(GpG) and -d(ApG) DNA adducts in HCT116 cells.
King CL; Ramachandran S; Chaney SG; Collins L; Swenberg JA; DeKrafft KE; Lin W; Cicurel L; Barbier M
Cancer Chemother Pharmacol; 2012 Mar; 69(3):665-77. PubMed ID: 21968950
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
Hagemeister T; Linscheid M
J Mass Spectrom; 2002 Jul; 37(7):731-47. PubMed ID: 12125006
[TBL] [Abstract][Full Text] [Related]
3. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
4. Separation and characterization of oxaliplatin dinucleotides from DNA using HPLC-ESI ion trap mass spectrometry.
Mowaka S; Linscheid M
Anal Bioanal Chem; 2008 Nov; 392(5):819-30. PubMed ID: 18709362
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
Ouzon-Shubeita H; Baker M; Koag MC; Lee S
Biochem J; 2019 Feb; 476(4):747-758. PubMed ID: 30709915
[TBL] [Abstract][Full Text] [Related]
6. RNA polymerases react differently at d(ApG) and d(GpG) adducts in DNA modified by cis-diamminedichloroplatinum(II).
Corda Y; Anin MF; Leng M; Job D
Biochemistry; 1992 Feb; 31(7):1904-8. PubMed ID: 1536834
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells.
Luo FR; Wyrick SD; Chaney SG
Oncol Res; 1998; 10(11-12):595-603. PubMed ID: 10367941
[TBL] [Abstract][Full Text] [Related]
8. Speciation of oxaliplatin adducts with DNA nucleotides.
Zayed A; Jones GD; Reid HJ; Shoeib T; Taylor SE; Thomas AL; Wood JP; Sharp BL
Metallomics; 2011 Oct; 3(10):991-1000. PubMed ID: 21858382
[TBL] [Abstract][Full Text] [Related]
9. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
Yamada K; Kato N; Takagi A; Koi M; Hemmi H
Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
[TBL] [Abstract][Full Text] [Related]
10. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
Ang WH; Myint M; Lippard SJ
J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.
Jerremalm E; Hedeland M; Wallin I; Bondesson U; Ehrsson H
Pharm Res; 2004 May; 21(5):891-4. PubMed ID: 15180350
[TBL] [Abstract][Full Text] [Related]
12. Development of an ultraperformance liquid chromatography/mass spectrometry method to quantify cisplatin 1,2 intrastrand guanine-guanine adducts.
Baskerville-Abraham IM; Boysen G; Troutman JM; Mutlu E; Collins L; Dekrafft KE; Lin W; King C; Chaney SG; Swenberg JA
Chem Res Toxicol; 2009 May; 22(5):905-12. PubMed ID: 19323581
[TBL] [Abstract][Full Text] [Related]
13. The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5'G in d(GpG).
Lempers EL; Bloemink MJ; Brouwer J; Kidani Y; Reedijk J
J Inorg Biochem; 1990 Sep; 40(1):23-35. PubMed ID: 2283508
[TBL] [Abstract][Full Text] [Related]
14. Reaction of (1R,2S,3S)-3-methylcyclohexanediamineplatinum(II) with DNA: isolation and characterization of the platinum-nucleotide adducts by means of HPLC and NMR spectroscopy.
Inagaki K; Sawaki K
Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):183-8. PubMed ID: 7728926
[TBL] [Abstract][Full Text] [Related]
15. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
Gibbons GR; Kaufmann WK; Chaney SG
Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
[TBL] [Abstract][Full Text] [Related]
16. 2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex.
Spingler B; Whittington DA; Lippard SJ
Inorg Chem; 2001 Oct; 40(22):5596-602. PubMed ID: 11599959
[TBL] [Abstract][Full Text] [Related]
17. DNA fragment conformations in adducts with Kiteplatin.
Margiotta N; Petruzzella E; Platts JA; Mutter ST; Deeth RJ; Ranaldo R; Papadia P; Marzilli PA; Marzilli LG; Hoeschele JD; Natile G
Dalton Trans; 2015 Feb; 44(8):3544-56. PubMed ID: 25144401
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.
Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ
Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460
[TBL] [Abstract][Full Text] [Related]
19. Nuclease digestion and mass spectrometric characterization of oligodeoxyribonucleotides containing 1,2-GpG, 1,2-ApG, and 1,3-GpXpG cisplatin intrastrand cross-links.
Williams RT; Nalbandian JN; Tu A; Wang Y
Clin Chim Acta; 2013 May; 420():160-70. PubMed ID: 23266768
[TBL] [Abstract][Full Text] [Related]
20. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects.
Lovejoy KS; Todd RC; Zhang S; McCormick MS; D'Aquino JA; Reardon JT; Sancar A; Giacomini KM; Lippard SJ
Proc Natl Acad Sci U S A; 2008 Jul; 105(26):8902-7. PubMed ID: 18579768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
